Bennington
Federal Rule Restricts Medicaid Funding for Youth Gender-Affirming Care
A new federal rule will end Medicaid coverage for gender-affirming hormone therapies and procedures for kids under age 18. The Centers for Medicare & Medicaid Services announced Tuesday a rule that prohibits state Medicaid plans from covering gender-affirming procedures for…
Last updated:
Key points
- A new federal rule from CMS eliminates federal Medicaid and CHIP funding for youth gender-affirming medical treatments starting Oct. 13.
- Patients currently on hormone therapy have a six-month federal funding transition period, while mental health services remain fully funded.
- Major medical groups like the AMA and AAP oppose the rule, emphasizing that healthcare decisions should stay between patients, families, and physicians.
NewsWK — New federal regulations will soon cut off federal Medicaid and Children’s Health Insurance Program funding for gender-affirming hormone therapies and medical procedures for minors. The policy change, announced by federal health administrators, directly impacts how public health programs manage coverage for young patients across Vermont and neighboring state lines.
Why it matters here
Families across Bennington, Shaftsbury, Pownal, and surrounding Southern Vermont communities rely heavily on state Medicaid programs and Dr. Dynasaur for youth healthcare services. Under the newly issued policy, federal matching dollars will no longer be available to cover specific gender-affirming medical treatments for individuals under age 18 in Medicaid programs, or under age 19 in the Children’s Health Insurance Program, known as CHIP.
Because Southern Vermont borders New York and Massachusetts, local residents often navigate cross-border medical care through regional health networks. State health agencies in Vermont, Massachusetts, and New York have historically maintained broad coverage protections for youth healthcare. However, the loss of federal financial reimbursement forces state administrators to decide whether to absorb full program costs using state tax dollars or adjust state coverage guidelines.
For local young people currently receiving hormone treatments through Medicaid or CHIP, federal funds will remain accessible for a six-month transition period. Additionally, federal funding for mental health support and counseling services remains fully intact under the new regulation.
Details of the federal rule change
The Centers for Medicare & Medicaid Services, commonly known as CMS, established October 13 as the official effective date for the new restrictions. The prohibition spans a range of medical treatments, including puberty blockers, cross-sex hormone therapies, and surgical procedures for young people.
Under the policy guidelines, federal funding for surgical procedures is completely prohibited for minors. Public health data indicates that surgical gender-affirming procedures on youth are extremely rare nationwide.
For youth who are actively undergoing hormone therapy under Medicaid or CHIP programs, CMS included a limited transition clause. State health plans are permitted to continue using federal matching funds for up to six months after the effective date to ensure continuity of care while treatment plans are re-evaluated.
Importantly, the agency explicitly stated that federal funds can still be utilized for behavioral health services, therapy, and mental healthcare for youth navigating gender identity questions.
Federal position and medical community response
The policy announcement reflects a sharp change in direction by federal administrators. U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. defended the regulatory change, asserting that gender-affirming procedures carry serious health risks and potential long-term complications for youth.
However, major national medical associations strongly oppose the federal decision. Leading professional organizations, including the American Medical Association and the American Academy of Pediatrics, maintain that age-appropriate gender-affirming care is safe, medically necessary, and crucial for improving mental health outcomes among youth.
Medical leaders emphasize that treatment decisions should remain between families and their healthcare teams. Dr. Susan Kressly, speaking during her tenure as president of the American Academy of Pediatrics, criticized governmental bans on pediatric gender-affirming care.
“These rules are a baseless intrusion into the patient-physician relationship,” Kressly stated regarding federal intervention in pediatric care choices. “Patients, their families, and their physicians, not politicians or government officials, should be the ones to make decisions together about what care is best for them.”
What comes next for local families
Local residents affected by the rule change should consult with their healthcare providers and state health coverage managers prior to the October 13 deadline. Parents and guardians with children currently receiving covered treatments should discuss how the six-month federal transition period applies to their specific care plan.
State officials in Vermont, New York, and Massachusetts are expected to issue detailed guidance to Medicaid enrollment offices and healthcare networks in the coming weeks. Local clinics and pediatric practices across Bennington County will continue offering mental health support services, which remain unaffected by the federal reimbursement ban.
This article was produced with the assistance of AI and reviewed by our editorial team.
